A phase Ia trial of Coversin in healthy volunteers

Trial Profile

A phase Ia trial of Coversin in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 12 Mar 2016

At a glance

  • Drugs Coversin (Primary)
  • Indications Haemolytic uraemic syndrome; Paroxysmal nocturnal haemoglobinuria
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 29 Jan 2016 Results were published in an Akari Therapeutics media release.
    • 21 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top